LivaNova Sorin Mitroflow Aortic Pericardial Heart Valve

Nazione: Singapore

Lingua: inglese

Fonte: HSA (Health Sciences Authority)

Commercializzato da:

LIVANOVA SINGAPORE PTE. LTD.

Classe:

Class D medical device

Prodotto da:

LivaNova Canada Corp.

Area terapeutica:

Cardiovascular

Indicazioni terapeutiche:

The Mitroflow valve is intended for the replacement of malfunctioning native or prosthetic aortic valves. The Mitroflow valve is suggested for use in those patients where long-term anticoagulation therapy may be undesirable for a variety of reasons, such as patients living in remote areas, patients with gastrointestinal or other bleeding problems, patients who may be expected to undergo other surgery, elderly patients and others where difficulty may be expected with anticoagulants, for social, or other medical reasons.

Dettagli prodotto:

Device System Info:[Sterile Medical Device], iv) steam sterilisation (jar), liquid chemical sterilant process (valve); Models: Sorin Mitroflow Aortic Pericardial Heart Valve - LXA19, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA21, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA23, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA25, Sorin Mitroflow Aortic Pericardial Heart Valve - LXA27, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA19, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA21, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA23, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA25, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA27, Sorin Mitroflow Aortic Pericardial Heart Valve - DLA29

Data dell'autorizzazione:

2011-12-22